|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/17 | |||
| C07K 14/71 | |||
| A61K 38/00 | |||
| C07K 14/72 | |||
| C07K 16/18 |
| (11) | Patento numeris | 2805967 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14175663.5 |
| Europos patento paraiškos padavimo data | 2008-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-04-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 899304 P | 2007-02-02 | US | |
| 927088 P | 2007-05-01 | US | |
| 931880 P | 2007-05-25 | US |
| (72) |
Knopf, John, US
Kumar, Ravindra, US
Seehra, Jasbir, US
|
| (73) |
Acceleron Pharma, Inc.,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | Variants derived from ActRIIB and uses therefor |
| Variants derived from ActRIIB and uses therefor |